Katelyn E. McCabe

525 total citations
17 papers, 434 citations indexed

About

Katelyn E. McCabe is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Katelyn E. McCabe has authored 17 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Katelyn E. McCabe's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Katelyn E. McCabe is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Nanoparticle-Based Drug Delivery (3 papers). Katelyn E. McCabe collaborates with scholars based in United States, South Africa and China. Katelyn E. McCabe's co-authors include Anna M. Wu, Tove Olafsen, Mark D. Girgis, James D. Marks, James S. Tomlinson, Vania Kenanova, Eric J. Lepin, Felix B. Salazar, Joe R. Delaney and Dwayne G. Stupack and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Infection and Immunity.

In The Last Decade

Katelyn E. McCabe

17 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katelyn E. McCabe United States 13 178 176 148 73 67 17 434
Xiaoli Hui China 10 106 0.6× 217 1.2× 187 1.3× 61 0.8× 36 0.5× 16 479
Heungnam Kim United States 10 102 0.6× 274 1.6× 152 1.0× 47 0.6× 85 1.3× 11 574
Thomas Sroka United States 10 147 0.8× 283 1.6× 101 0.7× 51 0.7× 79 1.2× 18 500
Qiuxiao Shi China 11 79 0.4× 138 0.8× 74 0.5× 109 1.5× 59 0.9× 18 322
Ruijiao Zhao China 7 125 0.7× 269 1.5× 89 0.6× 74 1.0× 35 0.5× 20 449
Komal Mandleywala United States 10 159 0.9× 106 0.6× 115 0.8× 65 0.9× 52 0.8× 16 345
Ze Tao China 11 76 0.4× 166 0.9× 75 0.5× 123 1.7× 60 0.9× 37 378
Katherine D. Castle United States 11 104 0.6× 137 0.8× 101 0.7× 89 1.2× 121 1.8× 13 401
Wanhua Yang China 12 86 0.5× 201 1.1× 173 1.2× 66 0.9× 49 0.7× 20 532

Countries citing papers authored by Katelyn E. McCabe

Since Specialization
Citations

This map shows the geographic impact of Katelyn E. McCabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katelyn E. McCabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katelyn E. McCabe more than expected).

Fields of papers citing papers by Katelyn E. McCabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katelyn E. McCabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katelyn E. McCabe. The network helps show where Katelyn E. McCabe may publish in the future.

Co-authorship network of co-authors of Katelyn E. McCabe

This figure shows the co-authorship network connecting the top 25 collaborators of Katelyn E. McCabe. A scholar is included among the top collaborators of Katelyn E. McCabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katelyn E. McCabe. Katelyn E. McCabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
McCabe, Katelyn E., Alena Bartáková, Joe R. Delaney, et al.. (2015). Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCNlow Neuroblastoma. PLoS ONE. 10(5). e0120815–e0120815. 22 indexed citations
2.
Delaney, Joe R., Chandni Patel, Katelyn E. McCabe, et al.. (2015). A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer. Oncotarget. 6(31). 31104–31118. 17 indexed citations
3.
Tavaré, Richard, Wen-Jun Wu, Kirstin A. Zettlitz, et al.. (2014). Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific 64Cu-DOTA conjugation. Protein Engineering Design and Selection. 27(10). 317–324. 26 indexed citations
4.
McCabe, Katelyn E., Karl Bacos, Dan Lü, et al.. (2014). Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma. Cell Death and Disease. 5(10). e1496–e1496. 48 indexed citations
5.
Girgis, Mark D., Noah Federman, Matthew M. Rochefort, et al.. (2013). An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles. Journal of Surgical Research. 185(1). 45–55. 23 indexed citations
6.
Federman, Noah, Jason Y. K. Chan, Jon O. Nagy, et al.. (2012). Enhanced Growth Inhibition of Osteosarcoma by Cytotoxic Polymerized Liposomal Nanoparticles Targeting the Alcam Cell Surface Receptor. Sarcoma. 2012. 1–11. 38 indexed citations
7.
McCabe, Katelyn E., Bin Liu, James D. Marks, et al.. (2011). An Engineered Cysteine-Modified Diabody for Imaging Activated Leukocyte Cell Adhesion Molecule (ALCAM)-Positive Tumors. Molecular Imaging and Biology. 14(3). 336–347. 21 indexed citations
8.
Girgis, Mark D., Vania Kenanova, Tove Olafsen, et al.. (2011). Anti-CA19-9 Diabody as a PET Imaging Probe for Pancreas Cancer. Journal of Surgical Research. 170(2). 169–178. 36 indexed citations
9.
Girgis, Mark D., Vania Kenanova, Tove Olafsen, et al.. (2011). Anti-CA19-9 Diabody As A PET Imaging Probe For Pancreas Cancer. Journal of Surgical Research. 165(2). 258–259. 2 indexed citations
10.
Girgis, Mark D., Tove Olafsen, Vania Kenanova, et al.. (2011). Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment. EJNMMI Research. 1(1). 24–24. 31 indexed citations
11.
Girgis, Mark D., Tove Olafsen, Vania Kenanova, et al.. (2011). CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer. PubMed. 2011. 1–9. 13 indexed citations
12.
McCabe, Katelyn E. & Anna M. Wu. (2010). Positive Progress in ImmunoPET—Not Just a Coincidence. Cancer Biotherapy and Radiopharmaceuticals. 25(3). 253–261. 42 indexed citations
13.
Lepin, Eric J., Jeffrey V. Leyton, Yu Zhou, et al.. (2010). An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. European Journal of Nuclear Medicine and Molecular Imaging. 37(8). 1529–1538. 50 indexed citations
14.
Sherman, David J., Vania Kenanova, Eric J. Lepin, et al.. (2010). A differential cell capture assay for evaluating antibody interactions with cell surface targets. Analytical Biochemistry. 401(2). 173–181. 6 indexed citations
15.
Barat, Bhaswati, Shannon J. Sirk, Katelyn E. McCabe, et al.. (2009). Cys-diabody Quantum Dot Conjugates (ImmunoQdots) for Cancer Marker Detection. Bioconjugate Chemistry. 20(8). 1474–1481. 49 indexed citations
16.
McCabe, Katelyn E., M. D. Mann, & M. D. Bowie. (1998). d -Lactate Production and [ 14 C]Succinic Acid Uptake by Adherent and Nonadherent Escherichia coli. Infection and Immunity. 66(3). 907–911. 5 indexed citations
17.
McCabe, Katelyn E., M. D. Mann, & M. D. Bowie. (1994). pH changes during in vitro adherence of Escherichia coli to HeLa cells. Infection and Immunity. 62(11). 5164–5167. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoli Hui Breakdown of academic impact, for papers by Heungnam Kim Breakdown of academic impact, for papers by Thomas Sroka Breakdown of academic impact, for papers by Qiuxiao Shi Breakdown of academic impact, for papers by Ruijiao Zhao Breakdown of academic impact, for papers by Komal Mandleywala Breakdown of academic impact, for papers by Ze Tao Breakdown of academic impact, for papers by Katherine D. Castle Breakdown of academic impact, for papers by Wanhua Yang
Rankless by CCL
2026